CBER Review “Paradigm Shift” Credited With Improved Cycle/Review Stats
This article was originally published in The Gray Sheet
Executive Summary
The Center for Biologics Evaluation & Research is working to identify problems with premarket applications earlier so they can be resolved in the first cycle of review, according to Robert Yetter, CBER associate director for review management